Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.61 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | TRPM8 | Q7Z2W7 | 8/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.43 |
| ▸ | PAFAH1B2 | P68402 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27826282 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL27636763 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL27636761 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL27615645 | 0.91 | FAAH (0.57) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL575551 | 0.90 | FAAH (0.48) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL19602995 | 0.88 | FAAH (0.60) | FAAHLPAR3LPAR2MEN1ALDH1A1 | |
| SCHEMBL11781621 | 0.87 | FAAH (0.53) | FAAHLPAR3LPAR2TRPM8LPAR1 | |
| SCHEMBL5484350 | 0.85 | FAAH (0.45) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| Dipentylamine SCHEMBL28770217 | 0.81 | S1PR2 (0.53) | FAAHALDH1A1 | |
| SCHEMBL588839 | 0.80 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0104967-B1 | PROCESS FOR PREPARING SULFONATED TRIARYL PHOSPHINES | RHONE-POULENC CHIMIE DE BASE (FR) | 1985-10-16 | — | — | EP | claimed |
| EP-0090692-A1 | Process for recovering and purifying a residual sulphuric acid containing titanium salts | RHONE-POULENC S.A. (FR) | 1983-10-05 | — | — | EP | claimed |
| US-20030194162-A1 | Fluorinated and halogenated phosphinic acids and their active metal derivatives | MININNI ROBERT M (US) | 2003-10-16 | — | — | US | disclosed |
| WO-2003082884-A1 | HALOGENATED PHOSPHINIC ACIDS AND THEIR ACTIVE METAL DERIVATIVES | PHOTON-X, INC. (US) | 2003-10-09 | — | — | WO | disclosed |
| US-20030189193-A1 | Fluorinated and halogenated phosphinic acids and their active metal derivatives | MININNI ROBERT M (US) | 2003-10-09 | — | — | US | disclosed |
| EP-0104967-B1 | PROCESS FOR PREPARING SULFONATED TRIARYL PHOSPHINES | RHONE-POULENC CHIMIE DE BASE (FR) | 1985-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030189193-A1 | Fluorinated and halogenated phosphinic acids and their active metal derivatives | PFAS, AFF1, NAF1 | FAAH 1183/4885LPAR3 105/4885LPAR2 349/4885 |
| US-20030194162-A1 | Fluorinated and halogenated phosphinic acids and their active metal derivatives | AFF1, PFAS, NAF1 | FAAH 1260/4885LPAR3 108/4885LPAR2 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.